GSK plc — RNS

Regulatory news across GSK, GSK

Date	TIDM	Time	Date	TIDM	TitleTitle (filtered)	Company	Source
19/02/26	GSK	15:30:00	19 Feb 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
19/02/26	GSK	07:00:04	19 Feb 2026	Transaction in Own Shares	GSK	Transaction in Own Shares	GSK PLC	RNS
18/02/26	GSK	07:00:03	18 Feb 2026	Transaction in Own Shares	GSK	Transaction in Own Shares	GSK PLC	RNS
17/02/26	GSK	15:30:00	17 Feb 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
17/02/26	GSK	15:30:00	17 Feb 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
17/02/26	GSK	07:00:09	17 Feb 2026	GSK - fourth tranche of share buyback programme	GSK	GSK - fourth tranche of share buyback programme	GSK PLC	RNS
17/02/26	GSK	07:00:02	17 Feb 2026	Exdensur approved by the European Commission	GSK	Exdensur approved by the European Commission	GSK PLC	RNS
16/02/26	GSK	15:30:00	16 Feb 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
16/02/26	GSK	15:30:00	16 Feb 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
16/02/26	GSK	15:30:00	16 Feb 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
11/02/26	GSK	15:30:01	11 Feb 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
11/02/26	GSK	15:30:01	11 Feb 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
11/02/26	GSK	15:30:01	11 Feb 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
11/02/26	GSK	15:30:00	11 Feb 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
10/02/26	GSK	07:00:13	10 Feb 2026	China CDE accepts Arexvy adults 60+ application	GSK	China CDE accepts Arexvy adults 60+ application	GSK PLC	RNS
09/02/26	GSK	15:30:00	9 Feb 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
06/02/26	GSK	10:30:00	6 Feb 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
06/02/26	GSK	07:00:09	6 Feb 2026	Nucala COPD approved by the European Commission	GSK	Nucala COPD approved by the European Commission	GSK PLC	RNS
05/02/26	GSK	15:30:00	5 Feb 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
04/02/26	GSK	07:00:03	4 Feb 2026	Final Results	GSK	Final Results	GSK PLC	RNS
02/02/26	GSK	15:00:00	2 Feb 2026	Total Voting Rights	GSK	Total Voting Rights	GSK PLC	RNS
26/01/26	GSK	07:00:07	26 Jan 2026	European Commission approves Arexvy for adults 18+	GSK	European Commission approves Arexvy for adults 18+	GSK PLC	RNS
20/01/26	GSK	07:05:00	20 Jan 2026	GSK to acquire RAPT Therapeutics	GSK	GSK to acquire RAPT Therapeutics	GSK PLC	RNS
20/01/26	GSK	07:00:07	20 Jan 2026	Agreement on changes to ViiV minority shareholding	GSK	Agreement on changes to ViiV minority shareholding	GSK PLC	RNS
16/01/26	GSK	15:30:00	16 Jan 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
15/01/26	GSK	15:30:00	15 Jan 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
13/01/26	GSK	15:30:01	13 Jan 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
07/01/26	GSK	07:05:00	7 Jan 2026	EC approval of Shingrix PFS	GSK	EC approval of Shingrix PFS	GSK PLC	RNS
07/01/26	GSK	07:00:04	7 Jan 2026	Positive phase 3 data for GSK's bepirovirsen	GSK	Positive phase 3 data for GSK's bepirovirsen	GSK PLC	RNS
06/01/26	GSK	07:00:05	6 Jan 2026	Exdensur approved in Japan	GSK	Exdensur approved in Japan	GSK PLC	RNS
05/01/26	GSK	15:30:00	5 Jan 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
05/01/26	GSK	15:00:00	5 Jan 2026	Total Voting Rights	GSK	Total Voting Rights	GSK PLC	RNS
05/01/26	GSK	07:00:07	5 Jan 2026	Nucala for adults with COPD approved in China	GSK	Nucala for adults with COPD approved in China	GSK PLC	RNS
22/12/25	GSK	15:30:01	22 Dec 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
22/12/25	GSK	07:00:08	22 Dec 2025	GSK to lower drug prices and expand access in US	GSK	GSK to lower drug prices and expand access in US	GSK PLC	RNS
22/12/25	GSK	07:00:04	22 Dec 2025	Transaction in Own Shares	GSK	Transaction in Own Shares	GSK PLC	RNS
19/12/25	GSK	07:00:03	19 Dec 2025	Transaction in Own Shares	GSK	Transaction in Own Shares	GSK PLC	RNS
18/12/25	GSK	07:00:04	18 Dec 2025	Transaction in Own Shares	GSK	Transaction in Own Shares	GSK PLC	RNS
17/12/25	GSK	07:00:10	17 Dec 2025	Exdensur (depemokimab ulla) approved by US FDA	GSK	Exdensur (depemokimab ulla) approved by US FDA	GSK PLC	RNS
17/12/25	GSK	07:00:07	17 Dec 2025	Transaction in Own Shares	GSK	Transaction in Own Shares	GSK PLC	RNS
16/12/25	GSK	07:00:08	16 Dec 2025	Exdensur (depemokimab) UK MHRA approval	GSK	Exdensur (depemokimab) UK MHRA approval	GSK PLC	RNS
16/12/25	GSK	07:00:05	16 Dec 2025	Transaction in Own Shares	GSK	Transaction in Own Shares	GSK PLC	RNS
15/12/25	GSK	07:00:05	15 Dec 2025	Transaction in Own Shares	GSK	Transaction in Own Shares	GSK PLC	RNS
12/12/25	GSK	13:50:15	12 Dec 2025	Nucala receives positive CHMP opinion for COPD	GSK	Nucala receives positive CHMP opinion for COPD	GSK PLC	RNS
12/12/25	GSK	13:41:03	12 Dec 2025	Depemokimab receives positive CHMP opinion	GSK	Depemokimab receives positive CHMP opinion	GSK PLC	RNS
12/12/25	GSK	07:00:08	12 Dec 2025	Positive CHMP opinion on Arexvy for all adults 18+	GSK	Positive CHMP opinion on Arexvy for all adults 18+	GSK PLC	RNS
12/12/25	GSK	07:00:04	12 Dec 2025	Transaction in Own Shares	GSK	Transaction in Own Shares	GSK PLC	RNS
11/12/25	GSK	17:54:05	11 Dec 2025	Blujepa approved in US for gonorrhoea indication	GSK	Blujepa approved in US for gonorrhoea indication	GSK PLC	RNS
11/12/25	GSK	15:30:00	11 Dec 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
11/12/25	GSK	09:00:00	11 Dec 2025	Block Listing Application	GSK	Block Listing Application	GSK PLC	RNS

Showing 151–200 of 1,058 announcements